ATREVIA® 360° stands out at the CVDL El Salvador 2025

October 2025 – ATREVIA® 360°, Petmedica®'s next-generation oral ecto-endoparasitic, was launched with great success at the León Veterinary Congress (CVDL) El Salvador 2025, setting a new standard in comprehensive protection for dogs. The event took place at the Hilton Hotel in San Salvador on October 22 and 23, 2025.
In collaboration with its strategic partner, Monteco Animal Health S.A. de C.V., Petmedica® presented this innovation to more than 500 attendees, including veterinarians, veterinary clinic owners, and animal health professionals. Dr. Luis Alfredo Chávez Balarezo, Petmedica®'s Technical Sales Manager, explained the key attributes and advanced mechanism of action of ATREVIA® 360°, generating significant interest in its effectiveness.

The formula combines three active ingredients—fluralaner, moxidectin, and praziquantel—providing up to 3 months of protection against fleas, ticks, and mites, with added protection against tapeworms and heartworms. Its SmartCap® technology ensures excellent palatability.
Petmedica® appreciates the warm reception from the Salvadoran veterinary community and reaffirms its commitment to continue developing innovative solutions that contribute to the well-being of pets.

To learn more about the complete ATREVIA® line, visit www.atrevia.vet.